|
GMP Fixes Reveal ‘More Issues’ Than Previously Thought: Hospira CFO
Amid lingering quality issues at a number of its manufacturing plants, Hospira reported some success in its discussions with the FDA but notes there are more trouble spots than the company previously thought.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives